Delivery Order SPE2DR25D2005-SPE2DR26FE8H2
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $13,259.50 on November 6, 2025, for the supply of Scemblix 40 mg tablets (60-count units). This is a firm fixed-price, non-set-aside contract with performance completion targeted for December 1, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $26,519.00 to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Scemblix 40 mg tablets in quantities of 60 units. This firm fixed-price, competitively awarded contract carries an ultimate completion date of September 26, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Scemblix (40 mg tablets) in quantities of 60s, with a ceiling value of $13,973.47 and an ultimate completion date of December 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Scemblix 40 mg tablets in quantities of 60 units. This is a firm fixed-price delivery order valued at $13,973.47, with an ultimate completion date of November 26, 2025. The award carries no set-aside designation and was competitively awarded. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order valued at $13,259.50 to AmerisourceBergen Drug Corp for the supply of Scemblix 40 mg tablets (60-count units) under a firm fixed-price contract. The order, issued on August 22, 2025, with an ultimate completion date of September 15, 2025, represents a competitively awarded, non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is...
- The Defense Logistics Agency (DLA) awarded a $13,259.50 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Scemblix 40 mg tablets (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 3, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a $13,973.47 delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Scemblix (40 mg tablets) in quantities of 60s. The contract represents a firm fixed-price delivery order with an ultimate completion date of December 23, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This award was competitively awarded without set-aside designation, reflecting AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $98,000 to AmerisourceBergen Drug Corp for the supply of Scemblix 40 mg tablets (60-count units). This competitive, firm fixed-price delivery order was issued on December 4, 2025, with an ultimate completion date of December 26, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $26,519.00 to AmerisourceBergen Drug Corp for supply of Scemblix 40 mg tablets (60 count) on September 5, 2025, with completion targeted for September 26, 2025. This firm fixed price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,259.50 to AmerisourceBergen Drug Corp for 60 tablets of Scemblix 40 mg, a pharmaceutical product, with completion scheduled for July 14, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FE8H2Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,973.47 to AmerisourceBergen Drug Corp for the supply of Scemblix 40 mg tablets (60-count units). This is a firm fixed-price, non-set-aside contract with a completion date of December 30, 2025, and an award date of December 8, 2025. The pharmaceutical product will be delivered to the company's Conshohocken, Pennsylvania location. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $1 billion pharmaceutical supply vehicle running through December 2026 that supports military healthcare systems globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement through its DLA relationship. The company maintains an extensive portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains and has demonstrated consistent capability to meet federal procurement requirements through open competition. This delivery order for Scemblix, a prescription medication, reflects the routine pharmaceutical supply operations the company executes for the Department of Defense and other federal healthcare systems under its prime vendor arrangements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.0k | 12/7/25 |